Investors & Media

Analyst Coverage

Firm Analyst E-Mail
Canaccord Genuity
John Newman Ph.D.
Jefferies LLC
Matthew J. Andrews
Laidlaw Capital Markets
Francois Brisebois
LifeSci Capital, LLC
Patrick Dolezal
Piper Jaffray & Co.
Charles Duncan Ph.D.
Raymond James and Associates
Laura Chico Ph.D.
Roth Capital Partners
Yasmeen Rahimi Ph.D.

Gemphire Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Gemphire Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Gemphire Therapeutics, Inc. or its management. Gemphire Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.